PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and...
ACEA Therapeutics (“ACEA”) will serve as exclusive territories distributor in Greater China, including mainland China, Taiwan, Hong Kong and Macau, with potential minimum purchase commitment for...
Aurobindo Pharma Generic Lidocaine Receives Approval in US
Enforcement Report - Week of June 5, 2024
Enforcement Report - Week of February 14, 2024
PALO ALTO, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, œScilex or œCompany), an innovative revenue-generating company focused on acquiring, developing and...
PALO ALTO, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, œScilex or œCompany), an innovative revenue-generating company focused on acquiring, developing and...
PALO ALTO, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex or Company), an innovative revenue-generating company focused on acquiring, developing and...
PALO ALTO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, œScilex or œCompany), an innovative revenue-generating company focused on acquiring, developing and...